跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 116 条关于
“Molteni Farmaceutici”
全部
116
临床试验
14
药物
36
机构
42
资讯
24
去年
OncoZenge and Molteni Farmaceutici Partner for BupiZenge Commercialization in Europe
去年
OncoZenge Partners with Meribel Pharma for BupiZenge Phase 3 Manufacturing
9个月前
OncoZenge Submits Phase III Clinical Trial Application for BupiZenge in Cancer-Related Oral Pain
去年
Chiesi Farmaceutici's Inhaled PI3Kδ Inhibitor Suggests Target Unsuitability for COPD Management
2个月前
Frontiers Launches Research Topic on Cellular Dysregulation in Autoimmune and Autoinflammatory Diseases, Seeking Novel Therapeutic Strategies
去年
Advancements in Bronchopulmonary Dysplasia Treatment: A Look into the 2024 Pipeline
去年
XOMA Royalty Acquires Pulmokine for $20 Million, Expanding PAH Portfolio with Seralutinib
去年
NCFB Pipeline Shows Promise with Over 15 Companies Developing New Therapies
5个月前
Veld Pharmaceuticals Partners with Chiesi to Launch Rare Disease Access Program Across Africa
去年
Protalix BioTherapeutics Appoints Gilad Mamlok as New CFO to Drive Growth Strategy
第 1 页,共 3 页
上一页
下一页